Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. ENSC
ENSC logo

ENSC

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ENSC News

Ensysce Biosciences Initiates Strategic Review to Enhance Shareholder Value

Feb 27 2026Benzinga

Kraig Biocraft Laboratories Launches Production Plan

Feb 27 2026Globenewswire

Kraig Biocraft Laboratories Launches Production Plan

Feb 27 2026Newsfilter

U.S. Stocks Drop Over 600 Points in Morning Trading

Feb 27 2026Benzinga

Applied Optoelectronics Reports Strong Q4, Shares Surge

Feb 27 2026Benzinga

Vanda Pharmaceuticals Shares Surge 33% in Pre-Market Trading

Feb 23 2026Benzinga

Credo Technology Raises Revenue Guidance Significantly

Feb 10 2026Benzinga

Ensysce Secures Brazilian Patent to Advance Safer Opioid Treatments

Jan 21 2026Yahoo Finance

Ensysce Initiates PF614 Phase 3 Enrollment, Advancing Towards Commercialization

Dec 12 2025Globenewswire

Ensysce Initiates PF614 Phase 3 Enrollment, Advancing Towards Commercialization

Dec 12 2025Newsfilter

Ensysce Secures FDA Approval for PF614 Commercial Production Pathway

Nov 24 2025Newsfilter

Ensysce Biosciences Under Review: Zacks Small-Cap Research Assigns $16.45 Price Target

Nov 17 2025Benzinga

Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)

Aug 15 2025Newsfilter

Ensysce Biosciences Narrows Loss in Q2

Aug 13 2025NASDAQ.COM

3 Penny Stocks to Watch Now, 4/24/25

Apr 24 2025TipRanks

Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

Apr 24 2025Benzinga